Interview: EMA’s Peter Arlett reflects on RWE approvals, early learnings from DARWIN

Regulatory NewsRegulatory NewsBiologics/ biosimilars/ vaccinesClinical TrialsEuropePharmaceuticalsRegulatory Intelligence/PolicyResearch, Design and Development